Exploring Automation to Scale Out Autologous CAR-T Manufacturing

• Examine how automation enables scalable, parallelised production of autologous CAR-T therapies without compromising quality
• Discuss how streamlined, modular manufacturing platforms can lower costs and accelerate patient access

Speakers:

Sarah Yuan

Chief Technology Officer

Cabaletta Bio